Clinical utility of varenicline for smokers with medical and psychiatric comorbidity

References

• Morbidity and Mortality2007 Chart Book on Cardiovascular, Lung, and Blood DiseasesInstitute NHLaB2007
   Google Scholar
• Chronic Obstructive Lung Disease (COPD)World Health Organization2008Fact sheet #315
   Google Scholar
• ManninoDMCOPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneityChest20021215 Suppl121S126S12010839
   PubMed Web of Science ®Google Scholar
• Global Strategy for Diagnosis, Management, and Prevention of COPDGlobal Initiative for Chronic Obstructive Lung Disease (GOLD) http://www.goldcopd.orgAccessed 29 Jun, 2009
   Google Scholar
• American Thoracic SocietyStandards for the diagnosis and care of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19951525 Pt 2S77S1217582322
   PubMed Web of Science ®Google Scholar
• GeijerRMSachsAPVerheijTJSalomePLLammersJWHoesAWIncidence and determinants of moderate COPD (GOLD II) in male smokers aged 40–65 years: 5-year follow upBr J Gen Pract20065653065666116953996
   PubMed Web of Science ®Google Scholar
• LindbergAJonssonACRonmarkELundgrenRLarssonLGLundbackBTen-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohortChest200512751544155215888826
   PubMed Web of Science ®Google Scholar
• LundbackBLindbergALindstromMNot 15 but 50% of smokers develop COPD? – Report from the Obstructive Lung Disease in Northern Sweden StudiesRespir Med200397211512212587960
   PubMed Web of Science ®Google Scholar
• GodtfredsenNSLamTHHanselTTCOPD-related morbidity and mortality after smoking cessation: status of the evidenceEur Respir J200832484485318827152
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEKileyJPEffects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health StudyJAMA199427219149715057966841
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEMurrayRPSmoking and lung function of Lung Health Study participants after 11 yearsAm J Respir Crit Care Med2002166567567912204864
   PubMed Web of Science ®Google Scholar
• KannerREConnettJEWilliamsDEBuistASEffects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health StudyAm J Med1999106441041610225243
   PubMed Web of Science ®Google Scholar
• AnthonisenNRSkeansMAWiseRAManfredaJKannerREConnettJEThe effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trialAnn Intern Med2005142423323915710956
   PubMed Web of Science ®Google Scholar
• RabeKFBegheBLuppiFFabbriLMUpdate in Chronic Obstructive Pulmonary Disease 2006Am J Respir Crit Care Med2007175121222123217545457
   PubMed Web of Science ®Google Scholar
• CelliBRMacNeeWAgustiAStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
   PubMed Web of Science ®Google Scholar
• TonnesenPCarrozziLFagerstromKOSmoking cessation in patients with respiratory diseases: a high priority, integral component of therapyEur Respir J200729239041717264326
   PubMed Web of Science ®Google Scholar
• O’DonnellDEAaronSBourbeauJCanadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2007 updateCan Respir J200714Suppl B5B32B
   PubMed Web of Science ®Google Scholar
• American College of Chest Physicians, American Thoracic Society, Asia Pacific Society of Respirology, Canadian Thoracic Society, European Respiratory Society, International Union Against Tuberculosis and Lung DiseaseSmoking and health: a physician’s responsibility. A statement of the joint committee on smoking and healthEur Respir J1995810180818118586144
   PubMed Web of Science ®Google Scholar
• FioreMCBaileyWCCohenSTreating Tobacco Use and Dependence: Clinical Practice GuidelineRockville, MD: USUS Department of Health and Human Services, Public Health Service2008
   Google Scholar
• KohlerCLBaileyWCTobacco dependence: a chronic diseaseChest2002121368668711888945
   PubMed Web of Science ®Google Scholar
• SteinbergMBSchmelzerACRichardsonDLFouldsJThe case for treating tobacco dependence as a chronic diseaseAnn Intern Med2008148755455618378950
   PubMed Web of Science ®Google Scholar
• HughesJRKeelyJNaudSShape of the relapse curve and long-term abstinence among untreated smokersAddiction2004991293814678060
   PubMed Web of Science ®Google Scholar
• YudkinPHeyKRobertsSWelchSMurphyMWaltonRAbstinence from smoking eight years after participation in randomised controlled trial of nicotine patchBMJ20033277405282912842953
   PubMed Web of Science ®Google Scholar
• CokkinidesVBandiPWardEJemalAThunMProgress and Opportunities in Tobacco ControlCA Cancer J Clin200656313514216737946
   PubMed Web of Science ®Google Scholar
• ConroyMBMajchrzakNEReganSSilvermanCBSchneiderLIRigottiNAThe association between patient-reported receipt of tobacco intervention at a primary care visit and smokers’ satisfaction with their health careNicotine Tob Res20057Suppl 1S29S3416036267
   PubMed Web of Science ®Google Scholar
• ColemanTCheaterFMurphyEQualitative study investigating the process of giving anti-smoking advice in general practicePatient Educ Couns2004252215916315132520
   PubMed Web of Science ®Google Scholar
• AveyardPWestRManaging smoking cessationBMJ20073357609374117615224
   PubMed Web of Science ®Google Scholar
• ButlerCCPillRStottNCQualitative study of patients’ perceptions of doctors’ advice to quit smoking: implications for opportunistic health promotionBMJ19983167148187818819632409
   PubMed Web of Science ®Google Scholar
• WestRSohalT“Catastrophic” pathways to smoking cessation: findings from national surveyBMJ2006332753945846016443610
   PubMed Web of Science ®Google Scholar
• PisingerCVestboJBorch-JohnsenKJorgensenTIt is possible to help smokers in early motivational stages to quit. The Inter99 studyPrev Med200540327828415533540
   PubMed Web of Science ®Google Scholar
• DunnCDerooLRivaraFPThe use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic reviewAddiction200196121725174211784466
   PubMed Web of Science ®Google Scholar
• Gance-ClevelandBMotivational interviewing: improving patient educationJ Pediatr Health Care2007212818817321907
   PubMedGoogle Scholar
• BurkeMVEbbertJOHaysJTTreatment of tobacco dependenceMayo Clin Proc2008834479483 quiz 483–47418380994
   PubMed Web of Science ®Google Scholar
• FioreMBaileyWCohenSTreating Tobacco Use and Dependence: Clinical Practice GuidelineRockville, MDUS Department of Health and Human Services Public Health Service2000
   Google Scholar
• PbertLHealthcare provider training in tobacco treatment: building competencyAm J Med Sci2003326424224714557743
   PubMed Web of Science ®Google Scholar
• US Quitline FactsNorth American Quitline Consortium http://www.naquitline.orgAccessed 27 Feb 2008
   Google Scholar
• KornitzerMBoutsenMDramaixMThijsJGustavssonGCombined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trialPrev Med199524141477740014
   PubMed Web of Science ®Google Scholar
• BlondalTGudmundssonLJOlafsdottirIGustavssonGWestinANicotine nasal spray with nicotine patch for smoking cessation: randomized trial with six year follow upBMJ19993182852889924052
   PubMed Web of Science ®Google Scholar
• JorenbyDELeischowSJNidesMA controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessationN Engl J Med1999340968569110053177
   PubMed Web of Science ®Google Scholar
• CroghanITHurtRDDakhilSRRandomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse preventionMayo Clin Proc200782218619517290726
   PubMed Web of Science ®Google Scholar
• TonstadSTønnesenPHajekPWilliamsKEBillingCBReevesKREffect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trialJAMA20062961647116820548
   PubMed Web of Science ®Google Scholar
• TashkinDPKannerRBaileyWSmoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trialLancet200135792681571157511377644
   PubMed Web of Science ®Google Scholar
• WagenaEJvan der MeerRMOsteloRJJacobsJEvan SchayckCPThe efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic reviewRespir Med200498980581515338790
   PubMed Web of Science ®Google Scholar
• TonnesenPMikkelsenKBremannLNurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral supportChest2006130233434216899830
   PubMed Web of Science ®Google Scholar
• WagenaEJKnipschildPGHuibersMJWoutersEFvan SchayckCPEfficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary diseaseArch Intern Med2005165192286229216246996
   PubMedGoogle Scholar
• StolermanIPJarvisMJThe scientific case that nicotine is addictivePsychopharmacology (Berl)19951171210 discussion 14–207724697
   PubMed Web of Science ®Google Scholar
• PontieriFETandaGOrziFDi ChiaraGEffects of nicotine on the nucleus accumbens and similarity to those of addictive drugsNature199638265882552578717040
   PubMed Web of Science ®Google Scholar
• DaniJAHeinemannSMolecular and cellular aspects of nicotine abuseNeuron19961659059088630247
   PubMed Web of Science ®Google Scholar
• CorringerPJLe NovereNChangeuxJPNicotinic receptors at the amino acid levelAnnu Rev Pharmacol Toxicol20004043145810836143
   PubMed Web of Science ®Google Scholar
• SmithJWMoggATafiELigands selective for α4β2 but not α3β4 or α7 nicotinic receptors generalise to the nicotine discriminative stimulus in the ratPsychopharmacology (Berl)2007190215717017115136
   PubMed Web of Science ®Google Scholar
• CoeJWBrooksPRVetelinoMGVarenicline: an α4β2 nicotinic receptor partial agonist for smoking cessationJ Med Chem200548103474347715887955
   PubMed Web of Science ®Google Scholar
• LesageMGShelleyDRossJTCarrollFICorrigallWAEffects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in ratsPharmacol Biochem Behav200991346146718817808
   PubMed Web of Science ®Google Scholar
• GonzalesDRennardSINidesMVarenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trialJAMA20062961475516820546
   PubMed Web of Science ®Google Scholar
• JorenbyDEHaysJTRigottiNAEfficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trialJAMA20062961566316820547
   PubMed Web of Science ®Google Scholar
• WilliamsKEReevesKRBillingCBJrPenningtonAMGongJA double-blind study evaluating the long-term safety of varenicline for smoking cessationCurr Med Res Opin200723479380117407636
   PubMed Web of Science ®Google Scholar
• OnckenCGonzalesDNidesMEfficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessationArch Intern Med2006166151571157716908789
   PubMed Web of Science ®Google Scholar
• NidesMOnckenCGonzalesDSmoking cessation with varenicline, a selective α4β2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-upArch Intern Med2006166151561156816908788
   PubMed Web of Science ®Google Scholar
• TsaiSTChoHJChengHSA randomized, placebo-controlled trial of varenicline, a selective α4β2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokersClin Ther20072961027103917692719
   PubMed Web of Science ®Google Scholar
• NakamuraMOshimaAFujimotoYMaruyamaNIshibashiTReevesKREfficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokersClin Ther20072961040105617692720
   PubMed Web of Science ®Google Scholar
• StapletonJAWatsonLSpirlingLIVarenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illnessAddiction2008103114615418028247
   PubMed Web of Science ®Google Scholar
• AubinHJBobakABrittonJRVarenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trialThorax200863871772418263663
   PubMed Web of Science ®Google Scholar
• CahillKSteadLFLancasterTNicotine receptor partial agonists for smoking cessationCochrane Database Syst Rev20083CD00610318646137
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationPublic Health Advisory: Important Information on Chantix (varenicline) http://www.fda.gov/CDER/Drug/advisory/varenicline.htmAccessed October 2, 2008
   Google Scholar
• Smoking cessation in subjects with mild-to-moderate chronic obstructive pulmonary disease (COPD) (ClinicalTrials.gov identifier: NCT0285012) http://clinicaltrials.gov/ct2/show/NCT0285012Accessed 18 Jun, 2009
   Google Scholar
• McRobbieHThornleySThe importance of treating tobacco dependenceRev Esp Cardiol200861662062818570783
   PubMed Web of Science ®Google Scholar
• AmbroseJABaruaRSThe pathophysiology of cigarette smoking and cardiovascular disease: an updateJ Am Coll Cardiol200443101731173715145091
   PubMed Web of Science ®Google Scholar
• Office on Smoking and HealthThe health consequences of smoking: cardiovascular disease A report of the surgeon generalRockville, MarylandHealth Service, US Department of Health and Human Services1983
   Google Scholar
• US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and HealthThe Health Consequences of Smoking: A Report of the Surgeon GeneralAtlanta2004
   Google Scholar
• WannametheeGShaperAGMacfarlanePWWalkerMRisk factors for sudden cardiac death in middle-aged British menCirculation1995916174917567882483
   PubMed Web of Science ®Google Scholar
• ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
   PubMed Web of Science ®Google Scholar
• RuttenFHCramerMJMGrobbeeDEUnrecognized heart failure in elderly patients with stable chronic obstructive pulmonary diseaseEur Heart J200526181887189415860516
   PubMed Web of Science ®Google Scholar
• LasserKBoydJWWoolhandlerSHimmelsteinDUMcCormickDBorDHSmoking and Mental Illness: A Population-Based Prevalence StudyJAMA2000284202606261011086367
   PubMed Web of Science ®Google Scholar
• McClureJBSwanGEJackLMood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking vareniclineJ Gen Intern Med200924556356919238488
   PubMed Web of Science ®Google Scholar
• AlhatemFBlackJEVarenicline-induced mania in a bipolar patientClin Neuropharmacol200932211711819512966
   PubMed Web of Science ®Google Scholar
• KutscherECStanleyMOehlkeKChantix-induced mental status changes in a young healthy femaleS D Med200962519319519489343
   PubMedGoogle Scholar
• US Food and Drug AdministrationPress Announcement: FDA: Boxed Warning on Serious Mental Health Events to be Required for Chantix and Zyban2009
   Google Scholar
• PfizerIPress Release: Pfizer Updates CHANTIX® (varenicline) Labeling in the United States Provides Specific Instruction to Physicians and Patients About Quitting Smoking with CHANTIX 2009
   Google Scholar
• RamFSSestiniPRegular inhaled short acting β2 agonists for the management of stable chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysisThorax200358758058412832670
   PubMed Web of Science ®Google Scholar
• WadboMLofdahlCGLarssonKEffects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled studyEur Respir J20022051138114612449166
   PubMed Web of Science ®Google Scholar
• SinDDMcAlisterFAManSFPAnthonisenNRContemporary Management of Chronic Obstructive Pulmonary Disease: Scientific ReviewJAMA2003290172301231214600189
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• BarrRGBourbeauJCamargoCARamFSTiotropium for stable chronic obstructive pulmonary disease: A meta-analysisThorax2006611085486216844726
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• NanniniLCatesCJLassersonTJPoolePCombined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20074CD00379417943798
   PubMed Web of Science ®Google Scholar
• BradleyJMLassersonTElbornSMacmahonJO’NeillBA systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPDChest2007131127828517218587
   PubMed Web of Science ®Google Scholar
• CranstonJMCrockettAJMossJRAlpersJHDomiciliary oxygen for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20054CD00174416235285
   PubMed Web of Science ®Google Scholar
• ScanlonPDConnettJEWallerLAAltoseMDBaileyWCBuistASSmoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health StudyAm J Respir Crit Care Med20001612 Pt 138139010673175
   PubMed Web of Science ®Google Scholar
• PoolePJChackoEWood-BakerRWCatesCJInfluenza vaccine for patients with chronic obstructive pulmonary diseaseCochrane Database Syst Rev20061CD00273316437444
   PubMed Web of Science ®Google Scholar
• GrangerRWaltersJPoolePJInjectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary diseaseCochrane Database Syst Rev20064CD00139017054135
   PubMed Web of Science ®Google Scholar